Mission and objective at KIND

The Center of Neurodevelopmental Disorders at Karolinska Institutet (KIND) is an internationally recognized competence center for research, development, and education in neurodevelopmental conditions. This includes, for example, autism, ADHD, language disorders (DLD), and intellectual disabilities.

The research performed at KIND leads to the development of better diagnostics, support, information, and treatment. We offer tailor-made courses for various professional groups and businesses. We collaborate with others in the community to spread knowledge and awareness about neurodiversity. Through our work, we aim to create a more inclusive society and a better life for people with neurodevelopmental conditions and their families.

KIND is a collaboration between Karolinska Institutet and Region Stockholm, with BUP KIND as the clinical unit. Organizationally, KIND is the department for neuropsychiatry at the Department of Women's and Children's Health and at the Center for Psychiatry Research. The director of KIND is Professor Sven Bölte, who is ranked top ten among the world's foremost autism researchers.

KIND started in 2010 and today has around 50 employees; psychologists, doctors, occupational therapists, biologists, nurses, coordinators and more.


Content reviewer: